Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Publications indexed to the term Piperidines

FacultyTitle
1Chronic treatment with URB597 ameliorates post-stress symptoms in a rat model of PTSD. (Fidelman S, Mizrachi Zer-Aviv T, Lange R, Hillard CJ, Akirav I) Eur Neuropsychopharmacol 2018 05;28(5):630-642       8 Citations
217β-Estradiol Potentiates the Reinstatement of Cocaine Seeking in Female Rats: Role of the Prelimbic Prefrontal Cortex and Cannabinoid Type-1 Receptors. (Doncheck EM, Urbanik LA, DeBaker MC, Barron LM, Liddiard GT, Tuscher JJ, Frick KM, Hillard CJ, Mantsch JR) Neuropsychopharmacology 2018 03;43(4):781-790       3 Citations
4A Subregion of the Parabrachial Nucleus Partially Mediates Respiratory Rate Depression from Intravenous Remifentanil in Young and Adult Rabbits. (Miller JR, Zuperku EJ, Stuth EAE, Banerjee A, Hopp FA, Stucke AG) Anesthesiology 2017 09;127(3):502-514       4 Citations
2Vandetanib and cabozantinib potentiate mitochondria-targeted agents to suppress medullary thyroid carcinoma cells. (Starenki D, Hong SK, Wu PK, Park JI) Cancer Biol Ther 2017 Jul 03;18(7):473-483       3 Citations
1Pimavanserin: A Novel Antipsychotic for Parkinson's Disease Psychosis. (Bozymski KM, Lowe DK, Pasternak KM, Gatesman TL, Crouse EL) Ann Pharmacother 2017 Jun;51(6):479-487       7 Citations
1Coordinated regulation of endocannabinoid-mediated retrograde synaptic suppression in the cerebellum by neuronal and astrocytic monoacylglycerol lipase. (Liu X, Chen Y, Vickstrom CR, Li Y, Viader A, Cravatt BF, Liu QS) Sci Rep 2016 10 24;6:35829       4 Citations
1Early clinical response to tofacitinib treatment as a predictor of subsequent efficacy: Results from two phase 3 studies of patients with moderate-to-severe plaque psoriasis. (Tan H, Valdez H, Griffins CE, Mrowietz U, Tallman A, Wolk R, Gordon K) J Dermatolog Treat 2017 02;28(1):3-7       5 Citations
1Therapeutic Elimination of the Type 1 Interferon Receptor for Treating Psoriatic Skin Inflammation. (Gui J, Gober M, Yang X, Katlinski KV, Marshall CM, Sharma M, Werth VP, Baker DP, Rui H, Seykora JT, Fuchs SY) J Invest Dermatol 2016 10;136(10):1990-2002       7 Citations
1Responses to drugs of abuse and non-drug rewards in leptin deficient ob/ob mice. (Muelbl MJ, Nawarawong NN, Clancy PT, Nettesheim CE, Lim YW, Olsen CM) Psychopharmacology (Berl) 2016 Jul;233(14):2799-811       11 Citations
1CB1 receptor antagonism blocks stress-potentiated reinstatement of cocaine seeking in rats. (McReynolds JR, Doncheck EM, Vranjkovic O, Ganzman GS, Baker DA, Hillard CJ, Mantsch JR) Psychopharmacology (Berl) 2016 Jan;233(1):99-109       16 Citations
1Disruption of peri-adolescent endocannabinoid signaling modulates adult neuroendocrine and behavioral responses to stress in male rats. (Lee TT, Hill MN, Hillard CJ, Gorzalka BB) Neuropharmacology 2015 Dec;99:89-97       10 Citations
1Full Fatty Acid Amide Hydrolase Inhibition Combined with Partial Monoacylglycerol Lipase Inhibition: Augmented and Sustained Antinociceptive Effects with Reduced Cannabimimetic Side Effects in Mice. (Ghosh S, Kinsey SG, Liu QS, Hruba L, McMahon LR, Grim TW, Merritt CR, Wise LE, Abdullah RA, Selley DE, Sim-Selley LJ, Cravatt BF, Lichtman AH) J Pharmacol Exp Ther 2015 Aug;354(2):111-20       19 Citations
1BDNF interacts with endocannabinoids to regulate cocaine-induced synaptic plasticity in mouse midbrain dopamine neurons. (Zhong P, Liu Y, Hu Y, Wang T, Zhao YP, Liu QS) J Neurosci 2015 Mar 11;35(10):4469-81       21 Citations
1Non-invasive cardiac output monitoring during sinus surgery. (Gollapudy S, Riess ML) J Anesth 2015 Aug;29(4):639       2 Citations
1Blockade of 2-arachidonoylglycerol hydrolysis produces antidepressant-like effects and enhances adult hippocampal neurogenesis and synaptic plasticity. (Zhang Z, Wang W, Zhong P, Liu SJ, Long JZ, Zhao L, Gao HQ, Cravatt BF, Liu QS) Hippocampus 2015 Jan;25(1):16-26       31 Citations
1Monoacylglycerol lipase inhibitor JZL184 is neuroprotective and alters glial cell phenotype in the chronic MPTP mouse model. (Fernández-Suárez D, Celorrio M, Riezu-Boj JI, Ugarte A, Pacheco R, González H, Oyarzabal J, Hillard CJ, Franco R, Aymerich MS) Neurobiol Aging 2014 Nov;35(11):2603-2616       34 Citations
2Monoacylglycerol lipase inhibition blocks chronic stress-induced depressive-like behaviors via activation of mTOR signaling. (Zhong P, Wang W, Pan B, Liu X, Zhang Z, Long JZ, Zhang HT, Cravatt BF, Liu QS) Neuropsychopharmacology 2014 Jun;39(7):1763-76       51 Citations
2Endocannabinoid signaling in hypothalamic-pituitary-adrenocortical axis recovery following stress: effects of indirect agonists and comparison of male and female mice. (Roberts CJ, Stuhr KL, Hutz MJ, Raff H, Hillard CJ) Pharmacol Biochem Behav 2014 Feb;117:17-24       28 Citations
2Mito-tempol and dexrazoxane exhibit cardioprotective and chemotherapeutic effects through specific protein oxidation and autophagy in a syngeneic breast tumor preclinical model. (Dickey JS, Gonzalez Y, Aryal B, Mog S, Nakamura AJ, Redon CE, Baxa U, Rosen E, Cheng G, Zielonka J, Parekh P, Mason KP, Joseph J, Kalyanaraman B, Bonner W, Herman E, Shacter E, Rao VA) PLoS One 2013;8(8):e70575       35 Citations
1Systemics to topicals in psoriasis: the unfilled need. (Lingam P, Nwe S, Gordon KB) Br J Dermatol 2013 Jul;169(1):2-3    
1NR2A- and NR2B-containing NMDA receptors in the prelimbic medial prefrontal cortex differentially mediate trace, delay, and contextual fear conditioning. (Gilmartin MR, Kwapis JL, Helmstetter FJ) Learn Mem 2013 May 15;20(6):290-4       38 Citations
1Mitochondria-targeted nitroxide, Mito-CP, suppresses medullary thyroid carcinoma cell survival in vitro and in vivo. (Starenki D, Park JI) J Clin Endocrinol Metab 2013 Apr;98(4):1529-40       23 Citations
2Adverse alterations in mitochondrial function contribute to type 2 diabetes mellitus-related endothelial dysfunction in humans. (Kizhakekuttu TJ, Wang J, Dharmashankar K, Ying R, Gutterman DD, Vita JA, Widlansky ME) Arterioscler Thromb Vasc Biol 2012 Oct;32(10):2531-9       48 Citations
3Pontine μ-opioid receptors mediate bradypnea caused by intravenous remifentanil infusions at clinically relevant concentrations in dogs. (Prkic I, Mustapic S, Radocaj T, Stucke AG, Stuth EA, Hopp FA, Dean C, Zuperku EJ) J Neurophysiol 2012 Nov;108(9):2430-41       26 Citations
1Modulation of ATP-induced LTP by cannabinoid receptors in rat hippocampus. (Ievglevskyi O, Palygin O, Kondratskaya E, Grebenyuk S, Krishtal O) Purinergic Signal 2012 Dec;8(4):705-13       6 Citations
1Prefrontal cortical anandamide signaling coordinates coping responses to stress through a serotonergic pathway. (McLaughlin RJ, Hill MN, Bambico FR, Stuhr KL, Gobbi G, Hillard CJ, Gorzalka BB) Eur Neuropsychopharmacol 2012 Sep;22(9):664-71       58 Citations
3Changes in regional cerebral blood flow and functional connectivity in the cholinergic pathway associated with cognitive performance in subjects with mild Alzheimer's disease after 12-week donepezil treatment. (Li W, Antuono PG, Xie C, Chen G, Jones JL, Ward BD, Franczak MB, Goveas JS, Li SJ) Neuroimage 2012 Apr 02;60(2):1083-91       69 Citations
2Cannabinoid receptor type 1 (CB1) activation inhibits small GTPase RhoA activity and regulates motility of prostate carcinoma cells. (Nithipatikom K, Gomez-Granados AD, Tang AT, Pfeiffer AW, Williams CL, Campbell WB) Endocrinology 2012 Jan;153(1):29-41       21 Citations
1Activity dependent protein degradation is critical for the formation and stability of fear memory in the amygdala. (Jarome TJ, Werner CT, Kwapis JL, Helmstetter FJ) PLoS One 2011;6(9):e24349       84 Citations
1Cannabinoid receptor involvement in stress-induced cocaine reinstatement: potential interaction with noradrenergic pathways. (Vaughn LK, Mantsch JR, Vranjkovic O, Stroh G, Lacourt M, Kreutter M, Hillard CJ) Neuroscience 2012 Mar 01;204:117-24       29 Citations
2Extracellular signal-regulated kinase signaling in the ventral tegmental area mediates cocaine-induced synaptic plasticity and rewarding effects. (Pan B, Zhong P, Sun D, Liu QS) J Neurosci 2011 Aug 03;31(31):11244-55       41 Citations
3Recruitment of prefrontal cortical endocannabinoid signaling by glucocorticoids contributes to termination of the stress response. (Hill MN, McLaughlin RJ, Pan B, Fitzgerald ML, Roberts CJ, Lee TT, Karatsoreos IN, Mackie K, Viau V, Pickel VM, McEwen BS, Liu QS, Gorzalka BB, Hillard CJ) J Neurosci 2011 Jul 20;31(29):10506-15       170 Citations
3Recovery of hippocampal network connectivity correlates with cognitive improvement in mild Alzheimer's disease patients treated with donepezil assessed by resting-state fMRI. (Goveas JS, Xie C, Ward BD, Wu Z, Li W, Franczak M, Jones JL, Antuono PG, Li SJ) J Magn Reson Imaging 2011 Oct;34(4):764-73       55 Citations
1Methylsulfonylnitrobenzoates, a new class of irreversible inhibitors of the interaction of the thyroid hormone receptor and its obligate coactivators that functionally antagonizes thyroid hormone. (Hwang JY, Huang W, Arnold LA, Huang R, Attia RR, Connelly M, Wichterman J, Zhu F, Augustinaite I, Austin CP, Inglese J, Johnson RL, Guy RK) J Biol Chem 2011 Apr 08;286(14):11895-908       25 Citations
1SOD1 and MitoTEMPO partially prevent mitochondrial permeability transition pore opening, necrosis, and mitochondrial apoptosis after ATP depletion recovery. (Liang HL, Sedlic F, Bosnjak Z, Nilakantan V) Free Radic Biol Med 2010 Nov 30;49(10):1550-60       61 Citations
2Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system. (Schlosburg JE, Blankman JL, Long JZ, Nomura DK, Pan B, Kinsey SG, Nguyen PT, Ramesh D, Booker L, Burston JJ, Thomas EA, Selley DE, Sim-Selley LJ, Liu QS, Lichtman AH, Cravatt BF) Nat Neurosci 2010 Sep;13(9):1113-9       354 Citations
2Endocannabinoid modulation of hyperaemia evoked by physiologically relevant stimuli in the rat primary somatosensory cortex. (Ho WS, Patel S, Thompson JR, Roberts CJ, Stuhr KL, Hillard CJ) Br J Pharmacol 2010 Jun;160(3):736-46       7 Citations
1Alvimopan for the management of postoperative ileus after bowel resection: characterization of clinical benefit by pooled responder analysis. (Ludwig K, Viscusi ER, Wolff BG, Delaney CP, Senagore A, Techner L) World J Surg 2010 Sep;34(9):2185-90       28 Citations
1Endogenous cannabinoid signaling is essential for stress adaptation. (Hill MN, McLaughlin RJ, Bingham B, Shrestha L, Lee TT, Gray JM, Hillard CJ, Gorzalka BB, Viau V) Proc Natl Acad Sci U S A 2010 May 18;107(20):9406-11       185 Citations
1IL-33 augments substance P-induced VEGF secretion from human mast cells and is increased in psoriatic skin. (Theoharides TC, Zhang B, Kempuraj D, Tagen M, Vasiadi M, Angelidou A, Alysandratos KD, Kalogeromitros D, Asadi S, Stavrianeas N, Peterson E, Leeman S, Conti P) Proc Natl Acad Sci U S A 2010 Mar 02;107(9):4448-53       194 Citations
3Clinically relevant infusion rates of mu-opioid agonist remifentanil cause bradypnea in decerebrate dogs but not via direct effects in the pre-Bötzinger complex region. (Mustapic S, Radocaj T, Sanchez A, Dogas Z, Stucke AG, Hopp FA, Stuth EA, Zuperku EJ) J Neurophysiol 2010 Jan;103(1):409-18       30 Citations
1Suppression of amygdalar endocannabinoid signaling by stress contributes to activation of the hypothalamic-pituitary-adrenal axis. (Hill MN, McLaughlin RJ, Morrish AC, Viau V, Floresco SB, Hillard CJ, Gorzalka BB) Neuropsychopharmacology 2009 Dec;34(13):2733-45       163 Citations
1Partial attenuation of cytotoxicity and apoptosis by SOD1 in ischemic renal epithelial cells. (Liang HL, Arsenault J, Mortensen J, Park F, Johnson CP, Nilakantan V) Apoptosis 2009 Oct;14(10):1176-89       16 Citations
3Blockade of 2-arachidonoylglycerol hydrolysis by selective monoacylglycerol lipase inhibitor 4-nitrophenyl 4-(dibenzo[d][1,3]dioxol-5-yl(hydroxy)methyl)piperidine-1-carboxylate (JZL184) Enhances retrograde endocannabinoid signaling. (Pan B, Wang W, Long JZ, Sun D, Hillard CJ, Cravatt BF, Liu QS) J Pharmacol Exp Ther 2009 Nov;331(2):591-7       108 Citations
3D2 dopamine receptor activation facilitates endocannabinoid-mediated long-term synaptic depression of GABAergic synaptic transmission in midbrain dopamine neurons via cAMP-protein kinase A signaling. (Pan B, Hillard CJ, Liu QS) J Neurosci 2008 Dec 24;28(52):14018-30       88 Citations
1Gastrointestinal tract recovery in patients undergoing bowel resection: results of a randomized trial of alvimopan and placebo with a standardized accelerated postoperative care pathway. (Ludwig K, Enker WE, Delaney CP, Wolff BG, Du W, Fort JG, Cherubini M, Cucinotta J, Techner L) Arch Surg 2008 Nov;143(11):1098-105       98 Citations
1Constitutive activity at the cannabinoid CB1 receptor is required for behavioral response to noxious chemical stimulation of TRPV1: antinociceptive actions of CB1 inverse agonists. (Fioravanti B, De Felice M, Stucky CL, Medler KA, Luo MC, Gardell LR, Ibrahim M, Malan TP Jr, Yamamura HI, Ossipov MH, King T, Lai J, Porreca F, Vanderah TW) J Neurosci 2008 Nov 05;28(45):11593-602       65 Citations
1Current pharmacologic treatment of dementia: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians. (Qaseem A, Snow V, Cross JT Jr, Forciea MA, Hopkins R Jr, Shekelle P, Adelman A, Mehr D, Schellhase K, Campos-Outcalt D, Santaguida P, Owens DK, American College of Physicians/American Academy of Family Physicians Panel on Dementia) Ann Intern Med 2008 Mar 04;148(5):370-8       234 Citations
2Inhibition of 2-arachidonoylglycerol catabolism modulates vasoconstriction of rat middle cerebral artery by the thromboxane mimetic, U-46619. (Hillard CJ, Ho WS, Thompson J, Gauthier KM, Wheelock CE, Huang H, Hammock BD) Br J Pharmacol 2007 Nov;152(5):691-8       23 Citations
1Vasopressin-induced nitric oxide production in rat inner medullary collecting duct is dependent on V2 receptor activation of the phosphoinositide pathway. (O'Connor PM, Cowley AW Jr) Am J Physiol Renal Physiol 2007 Aug;293(2):F526-32       20 Citations
1Postoperative ileus-related morbidity profile in patients treated with alvimopan after bowel resection. (Wolff BG, Weese JL, Ludwig KA, Delaney CP, Stamos MJ, Michelassi F, Du W, Techner L) J Am Coll Surg 2007 Apr;204(4):609-16       46 Citations
1Interactions between endocannabinoids and stress-induced decreased sensitivity to natural reward. (Rademacher DJ, Hillard CJ) Prog Neuropsychopharmacol Biol Psychiatry 2007 Apr 13;31(3):633-41       61 Citations
1Involvement of the endocannabinoid system in the ability of long-term tricyclic antidepressant treatment to suppress stress-induced activation of the hypothalamic-pituitary-adrenal axis. (Hill MN, Ho WS, Sinopoli KJ, Viau V, Hillard CJ, Gorzalka BB) Neuropsychopharmacology 2006 Dec;31(12):2591-9       88 Citations
2Inhibition of an equilibrative nucleoside transporter by cannabidiol: a mechanism of cannabinoid immunosuppression. (Carrier EJ, Auchampach JA, Hillard CJ) Proc Natl Acad Sci U S A 2006 May 16;103(20):7895-900       221 Citations
1Inhibition of restraint stress-induced neural and behavioural activation by endogenous cannabinoid signalling. (Patel S, Roelke CT, Rademacher DJ, Hillard CJ) Eur J Neurosci 2005 Feb;21(4):1057-69       200 Citations
1Anandamide content is increased and CB1 cannabinoid receptor blockade is protective during transient, focal cerebral ischemia. (Muthian S, Rademacher DJ, Roelke CT, Gross GJ, Hillard CJ) Neuroscience 2004;129(3):743-50       110 Citations
1Immunomodulatory and antitumor activity of Piper longum Linn. and piperine. (Sunila ES, Kuttan G) J Ethnopharmacol 2004 Feb;90(2-3):339-46       267 Citations
1Sympathetic and vascular consequences from remifentanil in humans. (Noseir RK, Ficke DJ, Kundu A, Arain SR, Ebert TJ) Anesth Analg 2003 Jun;96(6):1645-50, table of contents       49 Citations
1Microinjection of a cannabinoid receptor antagonist into the NTS increases baroreflex duration in dogs. (Rademacher DJ, Patel S, Hopp FA, Dean C, Hillard CJ, Seagard JL) Am J Physiol Heart Circ Physiol 2003 May;284(5):H1570-6       30 Citations
3The CB1 receptor antagonist SR141716 enhances stimulus-induced activation of the primary somatosensory cortex of the rat. (Patel S, Gerrits R, Muthian S, Greene AS, Hillard CJ) Neurosci Lett 2002 Dec 25;335(2):95-8       12 Citations
1Phase I clinical and pharmacokinetic trial of the cyclin-dependent kinase inhibitor flavopiridol. (Thomas JP, Tutsch KD, Cleary JF, Bailey HH, Arzoomanian R, Alberti D, Simon K, Feierabend C, Binger K, Marnocha R, Dresen A, Wilding G) Cancer Chemother Pharmacol 2002 Dec;50(6):465-72       110 Citations
1Evidence that 5-HT2A receptors in the hypothalamic paraventricular nucleus mediate neuroendocrine responses to (-)DOI. (Zhang Y, Damjanoska KJ, Carrasco GA, Dudas B, D'Souza DN, Tetzlaff J, Garcia F, Hanley NR, Scripathirathan K, Petersen BR, Gray TS, Battaglia G, Muma NA, Van de Kar LD) J Neurosci 2002 Nov 01;22(21):9635-42       64 Citations
1Acute treatment of migraine and the role of triptans. (Freitag FG) Curr Neurol Neurosci Rep 2001 Mar;1(2):125-32       7 Citations
1Cannabinoid CB(1) receptor agonists produce cerebellar dysfunction in mice. (Patel S, Hillard CJ) J Pharmacol Exp Ther 2001 May;297(2):629-37       68 Citations
1Inhibition of small intestinal secretion by cannabinoids is CB1 receptor-mediated in rats. (Tyler K, Hillard CJ, Greenwood-Van Meerveld B) Eur J Pharmacol 2000 Dec 08;409(2):207-11       51 Citations
1Comparison of sibrafiban with aspirin for prevention of cardiovascular events after acute coronary syndromes: a randomised trial. The SYMPHONY Investigators. Sibrafiban versus Aspirin to Yield Maximum Protection from Ischemic Heart Events Post-acute Coronary Syndromes. () Lancet 2000 Jan 29;355(9201):337-45       266 Citations
1Reversal of drug resistance in sarcoma-45 by the new calmodulin antagonist--trihydrochloride of [1,2,5-trimethyl-4-phenyl-4-beta-[N-(beta-ethylamino)-N-4'-methoxybe nzy l]-ethylamino] piperidine (AR-2). (Alexanian AR, Arutyunian NS) Invest New Drugs 1999;17(2):105-10       3 Citations
1Effects of CB(1) cannabinoid receptor activation on cerebellar granule cell nitric oxide synthase activity. (Hillard CJ, Muthian S, Kearn CS) FEBS Lett 1999 Oct 08;459(2):277-81       77 Citations
1Relationships between ligand affinities for the cerebellar cannabinoid receptor CB1 and the induction of GDP/GTP exchange. (Kearn CS, Greenberg MJ, DiCamelli R, Kurzawa K, Hillard CJ) J Neurochem 1999 Jun;72(6):2379-87       96 Citations
1Terikalant, an inward-rectifier potassium channel blocker, does not abolish the cardioprotection induced by ischemic preconditioning in the rat. (Schultz JE, Kwok WM, Hsu AK, Gross GJ) J Mol Cell Cardiol 1998 Sep;30(9):1817-25       6 Citations
2N-arachidonylethanolamide relaxation of bovine coronary artery is not mediated by CB1 cannabinoid receptor. (Pratt PF, Hillard CJ, Edgemond WS, Campbell WB) Am J Physiol 1998 01;274(1):H375-81       106 Citations
1Interactions between neuronal histamine and halothane anesthesia in rats. (Mammoto T, Yamamoto Y, Kagawa K, Hayashi Y, Mashimo T, Yoshiya I, Yamatodani A) J Neurochem 1997 Jul;69(1):406-11       15 Citations
1Inhibition of M3 muscarinic acetylcholine receptor-mediated Ca2+ influx and intracellular Ca2+ mobilization in neuroblastoma cells by the Ca2+/calmodulin-dependent protein kinase inhibitor 1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-trosyl]-4-phenylpiperazin e (KN-62). (Puhl HL, Raman PS, Williams CL, Aronstam RS) Biochem Pharmacol 1997 Apr 25;53(8):1107-14       9 Citations
1Antiarrhythmic action of the new calcium antagonist [1,2,5-trimethyl-4-phenyl-4-beta-(N-cyanoethyl-N-4'-methoxybenzyl) -ethylamino]piperidine dihydrochloride. (Alexanian AR, Arutyunian NS, Galoyan AA) Arzneimittelforschung 1996 Dec;46(12):1110-3       3 Citations
1Delayed rectification in single cells isolated from guinea pig sinoatrial node. (Anumonwo JM, Freeman LC, Kwok WM, Kass RS) Am J Physiol 1992 Mar;262(3 Pt 2):H921-5       58 Citations
1Small intestinal amyogenesia and dysmyogenesia induced by morphine and loperamide. (Sarna SK, Otterson MF) Am J Physiol 1990 Feb;258(2 Pt 1):G282-9       27 Citations
1Effect of cisapride, a new prokinetic agent, on esophageal motor function. (Gilbert RJ, Dodds WJ, Kahrilas PJ, Hogan WJ, Lipman S) Dig Dis Sci 1987 Dec;32(12):1331-6       52 Citations
1Serotonin as a mediator of cyclic flow variations in stenosed canine coronary arteries. (Ashton JH, Benedict CR, Fitzgerald C, Raheja S, Taylor A, Campbell WB, Buja LM, Willerson JT) Circulation 1986 Mar;73(3):572-8    
1Electrophysiologic effects of flecainide acetate and its major metabolites in the canine heart. (Guehler J, Gornick CC, Tobler HG, Almquist A, Schmid JR, Benson DW Jr, Benditt DG) Am J Cardiol 1985 Mar 01;55(6):807-12       23 Citations
1The effects of alpha 2-adrenergic and serotonergic receptor antagonists on cyclic blood flow alterations in stenosed canine coronary arteries. (Bush LR, Campbell WB, Kern K, Tilton GD, Apprill P, Ashton J, Schmitz J, Buja LM, Willerson JT) Circ Res 1984 Nov;55(5):642-52    
1Adrenergic component of renin release induced by vasodilating antihypertensive drugs in the rat. (Pettinger WA, Campbell WB, Keeton K) Circ Res 1973 Jul;33(1):82-6       84 Citations
jenkins-FCD Prod-353 9ccd8489072cb19f5b9f808bb23ed672c582f41e